Literature DB >> 7377017

PGE2, PGF2 alpha, and TXB2 biosynthesis by human rheumatoid synovia.

F Blotman, J Chaintreuil, P Poubelle, O Flandre, A Crastes de Paulet, L Simon.   

Abstract

Prostaglandins (PG) are currently suspected to be involved in human rheumatoid arthritis (RA). We have studied the PG [PGE2, PGF2 alpha, and Thromboxane B2 (TXB2)] biosynthesis capacity of normal (from amputations) and pathologic (osteoarthritis (OA) and RA) synovia. The measurement is done on the whole homogenate and microsomal fraction after 40 min incubation, without exogenous arachidonic acid (AA) or with a saturating concentration (25 micrograms/ml) of this compound, using a radioimmunoassay method. There is a considerable increase in PGE2 and PGF2 alpha production by the rheumatoid synovia and more PGE2 and PGF2 alpha are formed. This production is more marked for homogenates than microsomal fraction. The OA group is not homogeneous and does not differ significantly either from normals or from RA. The addition of AA considerably increases the biosynthesis of PG in both normal and pathologic tissue. For TXB2, the first results (four synovia) show no or a small biosynthesis in RA as well as in normals. Nevertheless, the levels before incubation seem higher in RA than in normal tissue.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377017

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Res        ISSN: 0361-5952


  8 in total

1.  Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.

Authors:  E Moilanen
Journal:  Agents Actions       Date:  1989-03

2.  Production of prostanoids by rheumatic synovial cells in vitro: effects of anti-inflammatory drugs on arachidonic acid metabolism.

Authors:  E Seppälä
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

3.  Eicosanoid production in rheumatoid synovitis.

Authors:  E Moilanen; J Alanko; M Nissilä; M Hämäläinen; H Isomäki; H Vapaatalo
Journal:  Agents Actions       Date:  1989-11

4.  Differences in prostanoid production between healthy and rheumatic synovia in vitro.

Authors:  E Moilanen; E Seppälä; M Nissilä; H Vapaatalo
Journal:  Agents Actions       Date:  1987-02

5.  Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.

Authors:  D F Jelinek; P A Thompson; P E Lipsky
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

6.  The influence of synovial fluid from patients with rheumatoid arthritis on the proliferation of peripheral blood lymphocytes and the prostanoid release from monocytes.

Authors:  M Seitz; W Deimann; D Gemsa
Journal:  Agents Actions       Date:  1981-12

7.  Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture.

Authors:  J A Salmon; G A Higgs; J R Vane; L Bitensky; J Chayen; B Henderson; B Cashman
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

Review 8.  Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?

Authors:  Qing-Chun Huang; Mao-Jie Wang; Xiu-Min Chen; Wan-Lin Yu; Yong-Liang Chu; Xiao-Hong He; Run-Yue Huang
Journal:  Oncotarget       Date:  2016-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.